| scholarly article | Q13442814 |
| P50 | author | Christopher L Robison | Q42722483 |
| P2093 | author name string | Debra L Yourick | |
| Lucille A Lumley | |||
| Lawrence C Tong | |||
| Marcio de Araujo Furtado | |||
| Spencer Lichtenstein | |||
| P2860 | cites work | Silver impregnation of degenerating axons in the central nervous system: a modified technic | Q34537421 |
| P433 | issue | 8 | |
| P921 | main subject | soman | Q408044 |
| status epilepticus | Q980709 | ||
| P304 | page(s) | 1503-1510 | |
| P577 | publication date | 2010-01-07 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats | |
| P478 | volume | 51 |
| Q35970290 | Acetylcholinesterase loosens the brain's cholinergic anti-inflammatory response and promotes epileptogenesis |
| Q51732627 | Age-related susceptibility to epileptogenesis and neuronal loss in male Fischer rats exposed to soman and treated with medical countermeasures. |
| Q28390872 | Animal models that best reproduce the clinical manifestations of human intoxication with organophosphorus compounds |
| Q54967844 | Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model. |
| Q38890240 | Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment |
| Q90392461 | Characterization and treatment of spontaneous recurrent seizures following nerve agent-induced status epilepticus in mice |
| Q51749309 | Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population. |
| Q28394870 | Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication |
| Q89617328 | Diapocynin, an NADPH oxidase inhibitor, counteracts diisopropylfluorophosphate-induced long-term neurotoxicity in the rat model |
| Q90855720 | Early polytherapy for benzodiazepine-refractory status epilepticus |
| Q43455535 | Editor's Highlight: Spatiotemporal Progression and Remission of Lesions in the Rat Brain Following Acute Intoxication With Diisopropylfluorophosphate. |
| Q88528293 | Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats |
| Q55256155 | Hypothermia Reduces Mortality, Prevents the Calcium Plateau, and Is Neuroprotective Following Status Epilepticus in Rats. |
| Q92799471 | Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model |
| Q96634684 | Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice |
| Q98779326 | Mechanism-based novel antidotes for organophosphate neurotoxicity |
| Q92803673 | Neurosteroid and benzodiazepine combination therapy reduces status epilepticus and long-term effects of whole-body sarin exposure in rats |
| Q37336739 | Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication |
| Q96306608 | Phenobarbital as alternate anticonvulsant for organophosphate-induced benzodiazepine-refractory status epilepticus and neuronal injury |
| Q56888044 | Poisoning with Soman, an Organophosphorus Nerve Agent, Alters Fecal Bacterial Biota and Urine Metabolites: a case for Novel Signatures for Asymptomatic Nerve Agent Exposure |
| Q38263071 | Potential pharmacological strategies for the improved treatment of organophosphate-induced neurotoxicity. |
| Q98196716 | Quantitative T2 MRI is predictive of neurodegeneration following organophosphate exposure in a rat model |
| Q92660747 | Sleep in the United States Military |
| Q58116786 | Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam |
| Q49310896 | Status Epilepticus: Behavioral and Electroencephalography Seizure Correlates in Kainate Experimental Models |
| Q48166589 | Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats |
| Q34552059 | The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology |
| Q30399944 | The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302. |
| Q30410510 | The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior |
| Q38100382 | Treatment of status epilepticus with ketamine, are we there yet? |
| Q43342937 | Vapor inhalation exposure to soman in conscious untreated rats: preliminary assessment of neurotoxicity. |
| Q26777019 | α-Linolenic Acid, A Nutraceutical with Pleiotropic Properties That Targets Endogenous Neuroprotective Pathways to Protect against Organophosphate Nerve Agent-Induced Neuropathology |
Search more.